Filing Flows › DarioHealth (DRIO) › Q1 2026 › vs Q4 2025
DarioHealth (DRIO) Q1 2026 vs Q4 2025 (quarter over quarter)
DarioHealth's revenue rose $353K (+7%) from $5.2M in Q4 2025 to $5.6M in Q1 2026. The biggest changes: Hardware and Consumable Products +$711K (+35%); Services −$358K (-11%).
DarioHealth, Q1 2026: revenue $5.6M (-17% year over year), operating margin -130.9%, net loss $8.2M, operating cash flow −$6.0M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Services | $2.8M | $3.2M | −$358K | -11% |
| Hardware and Consumable Products | $2.8M | $2.0M | $711K | +35% |
| Revenue | $5.6M | $5.2M | $353K | +7% |
| Net loss | $8.2M | $9.0M | −$782K | -9% |
| Costs & expenses | $13.8M | $14.3M | −$429K | -3% |
| Operating costs | $12.9M | $13.8M | −$900K | -7% |
| Interest & other, net | $883K | $386K | $497K | +129% |
| Income tax | $57K | $83K | −$26K | -31% |
| Cost of revenue | $2.4M | $2.4M | −$43K | -2% |
| Research & development | $2.4M | $2.6M | −$249K | -9% |
| Sales & marketing | $4.9M | $4.6M | $268K | +6% |
| General & admin | $3.2M | $4.1M | −$876K | -21% |
| Operating cash sources | $8.2M | $9.0M | −$782K | -9% |
| Depreciation & amortization | $524K | $534K | −$10K | -2% |
| Share-based compensation | $1.4M | $2.0M | −$597K | -29% |
| Working capital & other | $259K | $572K | −$313K | -55% |
| Cash used in operations | $6.0M | $5.9M | $138K | +2% |
| Net loss absorbed | $8.2M | $9.0M | −$782K | -9% |
Questions
How much did DarioHealth's revenue grow quarter over quarter in Q1 2026?
DarioHealth's revenue rose $353K (+7%) from $5.2M in Q4 2025 to $5.6M in Q1 2026.
What drove DarioHealth's revenue change in Q1 2026?
Hardware and Consumable Products +$711K (+35%); Services −$358K (-11%).